The Advocate - June 8, 1961

Original title (1951-1987)--The Advocate: official publication of the Archdiocese of Newark (N.J.)

Evaluation of Knowledge Level on Sexually Transmitted Diseases of Medical School Students Who Received HPV Vaccination

Introduction: Sexually transmitted diseases (STDs) can adversely affect sexual and reproductive health, especially starting from ado- lescence, in addition to the mortality and morbidity they cause. Of these, human papilloma virus (HPV) is of great importance because it is very common and can be prevented by vaccination. More widespread vaccination can be achieved by increasing awareness and knowledge, both in society and among physicians. In this study, it was aimed to evaluate the knowledge level of med school students, who had HPV vaccine, about sexually transmitted diseases.Materials and Methods: Socio-demographic characteristics and knowledge levels about sexually transmitted diseases were evaluated by filling out a questionnaire for med school students who were vaccinated in 2022 in our hospital. The dataset were put in Microsoft Office Excel program.Results: Total of 212 participants (169 females 79.7%; 43 males 20.3%, mean age 22.18 +/- 2.15 years) were included in the study. Participants stated that they heard about HPV vaccine; through classes 74.5% (n= 158), friends/family 43.4% (n= 92), and social media/TV 41% (n= 87). They defined the safest contraceptive method for STD as using condoms 68.9%, not having sexual intercourse 18.4%, and monogamy 12.7%. Question about causative relation with cancer development of listed agents answered as: HPV (99.1%), hepatitis B (70.8%), syphilis (6.6%), and Gonorrhea (3.8%).Conclusion: Increasing level of knowledge of young physicians and physician candidates about sexually transmitted diseases will certainly contribute to the awareness and vaccination of society. We believe that being aware of our shortcomings in this regard and reducing sexual health education to a much earlier age, will help solve this issue

A Case of Chickenpox Developing 11 Years after Renal Transplantation

WOS: 000514116300017In solid organ transplant recipients, it is recommended that the necessary vaccinations be completed at least 4 weeks before transplant. Chickenpox infection in adulthood can lead to serious clinical conditions such as pneumonia, hepatitis, and central nervous system infections. Herein, the case of chickenpox in a 36-year-old female patient with renal transplantation for end-stage renal disease due to vesicoureteral reflux 11 years previously and without a history of chickenpox or its vaccination before and after transplantation is reported. in this case, because of the development of thrombocytopenia associated with intravenous acyclovir, treatment was successfully concluded with oral valacyclovir

Cytomegalovirus Disease Causing Outbreak in Family Members

WOS: 000488951800014Primary cytomegalovirus (CMV) infection generally occurs during childhood/early adolescence and is usually an asymptomatic or mild and self-limiting disease in immunocompetent patients. Mononucleosis-like syndrome due to primary CMV may occur in middle-aged or advanced-aged adults, though rare. Three middle-aged patients from the same family admitted to our clinic with acute CMV infection. Two of the three cases were hospitalized, CMV antibodies were examined and at the same time the third case had an acute CMV infection. CMV transmission among middle-aged family members Is very rare. This study reports three cases of acute CMV infection and it's transmission from person to person in the same family

COVID-19-related anxiety in people living with HIV: an online cross-sectional study

Tasbakan, meltem/0000-0002-4689-720XWOS:000600735500006PubMed: 32777899Background/aim: The emergence of the coronavirus disease 2019 (COVID-19) outbreak has had an enormous emotional impact on sonic vulnerable groups, such as people living with human immunodeficiency virus (HIV) (PLHIV). This study was planned with the aim of assessing the anxiety levels of PLHIV and the sources of their anxiety. Materials and methods: A web-based questionnaire was sent to PLHIV using the virtual snowball sampling method. The questionnaire included questions about sociodemographic status, information about HIV infection, and the Beck Anxiety Inventory (BAI). Additionally, some opinions of the participants about COVID-19 were asked. Results: A total of 307 respondents, with a median age of 33 years, from 32 different cities, participated in the study. More than half of the respondents reported the belief that COVID-19 was not sufficiently well-known by the medical community and nearly 45% believed that they would have snore complications if they contracted COVID-19. One-fourth of the participants had anxiety. Having a preexisting psychiatric disorder, perceiving that they were practicing insufficient preventive measures, not being sure about the presence of any individuals with COVID-19 in their environment, and living with a household member with a chronic disease were found to be the risk factors of PLHIV for having anxiety during this pandemic. The BAI scores were correlated with the patient-reported anxiety levels about the spread of COVID-19 in Turkey, acquiring COVID-19, transmitting COVID-19 to another person, and transmitting HIV to another person. Among the stated conditions, the most common concern was the spread of COVID-19 all over the country, while the least common was transmitting HIV to someone else. Conclusion: The results revealed that a significant proportion of the sample had anxiety, and the findings were essential for developing evidence-based strategies for decreasing the anxiety of PLHIV, especially for those who had risk factors and to provide them with better health care during this pandemic or other pandemic-like crises

Tigecycline versus INR increase; more than expected?

Akdag, Damla/0000-0003-1700-7578WOS: 000514053100001PubMed: 31994416Objectives: the aim of the study was to investigate the frequency of tigecycline-associated INR abnormality. Methods: Patients who were hospitalized between June and September 2016 and treated with tigecycline including therapy were extracted from hospital database and retrospectively reviewed. INR values at the beginning and end of treatment were compared. Results: A total of 79 patients who received tigecycline were identified by analyzing the hospital database. Nineteen patients were excluded from the study since INR was not measured at the beginning and/or end of treatment. in 55 of the 60 patients, INR levels were within normal limits (0.9-1.2) at the beginning of treatment while 19 of these 55 (34,5%) had prolonged INR after treatment. Prolongation was found to be mild (1.01-1.25 x ULN-upper limit of normal) in 12 of 19 patients, moderate (1.26-1.5 x ULN) in six and severe (1.51-3.0 x ULN) in one. in 10 of 19 patients, tigecycline was stopped, and the INR values normalized. There was no difference in INR abnormality rate between tigecycline monotherapy versus combination therapy receiving cases (19/27-33% vs. 10/33-30% p:1). Conclusion: These data show that INR prolongation may develop as common as 34.6% during tigecycline therapy. Regular INR follow-up may be beneficial in cases receiving tigecycline

Is Every Foot Wound a Diabetic Foot Infection in Diabetic Patients? A Case of Kaposi Sarcoma

WOS: 000511368300018[No abstract available